These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 17524511

  • 1. In vivo imaging of cidofovir treatment of cowpox virus infection.
    Goff A, Twenhafel N, Garrison A, Mucker E, Lawler J, Paragas J.
    Virus Res; 2007 Sep; 128(1-2):88-98. PubMed ID: 17524511
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment of cowpox virus respiratory infections in mice with ribavirin as a single agent or followed sequentially by cidofovir.
    Smee DF, Bailey KW, Sidwell RW.
    Antivir Chem Chemother; 2000 Jul; 11(4):303-9. PubMed ID: 10950392
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge.
    Bray M, Martinez M, Smee DF, Kefauver D, Thompson E, Huggins JW.
    J Infect Dis; 2000 Jan; 181(1):10-9. PubMed ID: 10608745
    [Abstract] [Full Text] [Related]

  • 8. Effects of cidofovir treatment on cytokine induction in murine models of cowpox and vaccinia virus infection.
    Knorr CW, Allen SD, Torres AR, Smee DF.
    Antiviral Res; 2006 Nov; 72(2):125-33. PubMed ID: 16782209
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative effects of cidofovir and cyclic HPMPC on lethal cowpox and vaccinia virus respiratory infections in mice.
    Smee DF, Bailey KW, Sidwell RW.
    Chemotherapy; 2003 Jun; 49(3):126-31. PubMed ID: 12815205
    [Abstract] [Full Text] [Related]

  • 15. Cutaneous infections of mice with vaccinia or cowpox viruses and efficacy of cidofovir.
    Quenelle DC, Collins DJ, Kern ER.
    Antiviral Res; 2004 Jul; 63(1):33-40. PubMed ID: 15196818
    [Abstract] [Full Text] [Related]

  • 16. Aerosolized cidofovir is retained in the respiratory tract and protects mice against intranasal cowpox virus challenge.
    Roy CJ, Baker R, Washburn K, Bray M.
    Antimicrob Agents Chemother; 2003 Sep; 47(9):2933-7. PubMed ID: 12936997
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bioterrorism. Blocking smallpox: a second defense.
    Cohen J.
    Science; 2001 Oct 19; 294(5542):500. PubMed ID: 11641477
    [No Abstract] [Full Text] [Related]

  • 20. A-type inclusion bodies: a factor influencing cowpox virus lesion pathogenesis.
    Leite JA, da Fonseca FG, de Souza Trindade G, Abrahão JS, Arantes RM, de Almeida-Leite CM, dos Santos JR, Guedes MI, Ribeiro BM, Bonjardim CA, Ferreira PC, Kroon EG.
    Arch Virol; 2011 Apr 19; 156(4):617-28. PubMed ID: 21212997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.